Head of Platform Technologies – Recombinant Mammalian MSAT

Sanofi; Framingham (MA); Hybrid; USD 179,000 - 258,000; Full time

Job summary

Sanofi in Framingham, MA seeks Head of Platform Technologies to lead the MSAT Recombinant Mammalian CoE, building state-of-the-art innovation labs and advancing platform technologies like perfusion cell culture and continuous purification.

You will mentor a nationwide team, collaborate with R&D, Manufacturing and external partners, and drive global MSAT innovation while representing scientific leadership in internal and external forums. Hybrid schedule with onsite work three days a week.

Qualifications

• PhD degree in Chemical/Biological/Sciences/Engineering is preferred.
• Master's degree is required.
• 10+ years of experience in biopharmaceutical industry is required.
• 5+ years of hands-on experience in biologics drug substance process development, technology development or manufacturing support is required.
• Demonstrated experience leading bioprocess and biomanufacturing innovation initiatives from concept through implementation.
• Deep knowledge of bioprocess development and operations (e.g., upstream, downstream, drug-substance stability).
• Familiarity with laboratory, pilot-scale, and large-scale manufacturing operations.
• Process knowledge across multiple modalities (e.g. mAbs, small protein and peptide, bioconjugates, nucleotides, Gene/cell therapy, organic chemistry etc.).
• Prior experience of managing suppliers, contractor manufacturing or contract research partners.
• Excellent scientific background and effective communication skills.
• Demonstrated ability to manage and prioritize multiple projects and consistently meet deadlines.
• Oral and written fluency in English.

Responsibilities

• Lead the evaluation of next-generation platform technologies including perfusion cell culture, continuous purification, PAT, smart manufacturing, and novel process chemistries.
• Develop the MSAT position on development data package requirements, at-scale operational readiness, transferability, lab-scale model expectations, and MSAT training needs.
• Align platform-technology initiatives with broader organizational objectives such as second-generation program development and yield improvement.
• Establish and maintain innovation laboratory infrastructures within the COE.
• Partner with upstream, downstream, and analytical teams to advance lab digitization and automation.
• Build and maintain laboratory and pilot-scale capabilities for the smart-lab future concept.
• Build and maintain strategic relationships with external partners and vendors.
• Oversee collaboration with external suppliers for manufacturing investigations, process development, and technology co-development.
• Coordinate activities with MSAT, R&D, and Global Procurement.
• Drive global MSAT innovation initiatives with other platforms (Vaccines, Drug Product, Microbial).
• Promote knowledge sharing and best-practice adoption across teams.
• Represent MSAT’s scientific excellence in internal and external forums.
• Strengthen Sanofi’s reputation as a leader in biopharmaceutical manufacturing innovation.
• Contribute SME input for laboratory work and technology transfers; collaborate with cross-functional teams.

Skills

Leadership

Biopharma knowledge

Project management

Communication

English fluency

Education

PhD preferred

Master's degree required

Job description

Sanofi in Framingham, MA seeks Head of Platform Technologies to lead the MSAT Recombinant Mammalian CoE, building state-of-the-art innovation labs and advancing platform technologies like perfusion cell culture and continuous purification.

You will mentor a nationwide team, collaborate with R&D, Manufacturing and external partners, and drive global MSAT innovation while representing scientific leadership in internal and external forums. Hybrid schedule with onsite work three days a week.